Statement Of Income And Retained Earnings

HISAMITSU PHARMACEUTICAL CO.,INC. - Filing #7566829

Concept 2022-03-01 to
2023-02-28
2022-03-01 to
2023-02-28
2022-03-01 to
2023-02-28
2022-03-01 to
2023-02-28
2022-03-01 to
2023-02-28
2021-03-01 to
2022-02-28
2021-03-01 to
2022-02-28
2021-03-01 to
2022-02-28
2021-03-01 to
2022-02-28
2021-03-01 to
2022-02-28
Statement of income and retained earnings
Statement of income and retained earnings
Operating profit (loss)
10,850,000,000 JPY
11,599,000,000 JPY
8,615,000,000 JPY
9,337,000,000 JPY
Non-operating income
Non-operating income
3,235,000,000 JPY
4,791,000,000 JPY
2,531,000,000 JPY
3,453,000,000 JPY
Non-operating expenses
Non-operating expenses
27,000,000 JPY
340,000,000 JPY
538,000,000 JPY
152,000,000 JPY
Ordinary profit (loss)
14,057,000,000 JPY
16,051,000,000 JPY
10,608,000,000 JPY
12,638,000,000 JPY
Extraordinary income
Extraordinary income
453,000,000 JPY
453,000,000 JPY
660,000,000 JPY
660,000,000 JPY
Extraordinary losses
Extraordinary losses
351,000,000 JPY
391,000,000 JPY
1,331,000,000 JPY
342,000,000 JPY
Profit (loss) before income taxes
14,159,000,000 JPY
16,113,000,000 JPY
9,936,000,000 JPY
12,956,000,000 JPY
Income taxes - current
3,525,000,000 JPY
4,419,000,000 JPY
3,394,000,000 JPY
3,727,000,000 JPY
Income taxes - deferred
219,000,000 JPY
-432,000,000 JPY
-627,000,000 JPY
-633,000,000 JPY
Profit (loss)
10,414,000,000 JPY
10,414,000,000 JPY
10,414,000,000 JPY
12,126,000,000 JPY
10,414,000,000 JPY
7,169,000,000 JPY
7,169,000,000 JPY
7,169,000,000 JPY
9,862,000,000 JPY
7,169,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.